^{1Laplante, M. & Sabatini, D.M. (2009). mTOR signaling at a glance. Journal of Cell Science2009 · DOI 10.1242/jcs.051011Open reference} ^{2Hardie, D.G. (2007). AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nature Reviews Molecular Cell Biology2007 · DOI 10.1038/nrm2193Open reference} ^{3(2009). ULK1.ATG1.FIP200 complex. Autophagy2009 · DOI 10.4161/auto.5.6.8902Open reference} ^{4He, C. & Levine, B. (2010). The Beclin 1 interactome. Current Opinion in Cell Biology2010 · DOI 10.1016/j.ceb.2010.02.008Open reference} ^{5(2011). Autophagy machinery in mammalian cells. Cell Death & Differentiation2011 · DOI 10.1038/cdd.2010.82Open reference} ^{6(2000). LC3, a mammalian homologue of yeast Apg8p. EMBO Journal2000 · DOI 10.1093/emboj/cdg440Open reference} ^{7(2004). The role of autophagy during the newborn period. Nature2004 · DOI 10.1038/nature03029Open reference} ^{8(2003). Mouse Apg16L, a novel WD-repeat protein. Journal of Biological Chemistry2003 · DOI 10.1074/jbc.M212599200Open reference} ^{9(2006). Lysosomal cathepsins and cell death. Antioxidants & Redox Signaling2006 · DOI 10.1089/ars.2006.8.188Open reference} ^{10(2000). Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy. Nature2000 · DOI 10.1038/35065114Open reference} ^{2Hardie, D.G. (2007). AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nature Reviews Molecular Cell Biology2007 · DOI 10.1038/nrm2193Open reference}0 ^{2Hardie, D.G. (2007). AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nature Reviews Molecular Cell Biology2007 · DOI 10.1038/nrm2193Open reference}1 ^{2Hardie, D.G. (2007). AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nature Reviews Molecular Cell Biology2007 · DOI 10.1038/nrm2193Open reference}2 ^{2Hardie, D.G. (2007). AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nature Reviews Molecular Cell Biology2007 · DOI 10.1038/nrm2193Open reference}3 ^{2Hardie, D.G. (2007). AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nature Reviews Molecular Cell Biology2007 · DOI 10.1038/nrm2193Open reference}4 ^{2Hardie, D.G. (2007). AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nature Reviews Molecular Cell Biology2007 · DOI 10.1038/nrm2193Open reference}5

Autophagy-Impaired Neurons
Lineage	Neuron > Autophagy-Impaired
Markers	p62, LC3-II, LAMP2, Beclin-1, ATG5, ATG7
Brain Regions	Substantia Nigra, Hippocampus, Cerebral Cortex, Cerebellum
Disease Relevance	Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, ALS, Batten Disease

^{2Hardie, D.G. (2007). AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nature Reviews Molecular Cell Biology2007 · DOI 10.1038/nrm2193Open reference}6

Autophagy-Impaired Neurons

Overview

Autophagy Impaired Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications. ^{2Hardie, D.G. (2007). AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nature Reviews Molecular Cell Biology2007 · DOI 10.1038/nrm2193Open reference}7

Pathway / Mechanism Diagram

graph TD
    A["Nutrient Deprivation / Stress"] --> B["AMPK Activation"]
    B --> C["ULK1 Complex Activation"]
    A --> D["mTORC1 Inhibition"]
    D --> C
    C --> E["Phagophore Nucleation (VPS34/Beclin-1)"]
    E --> F["LC3 Lipidation (LC3-II)"]
    F --> G["Autophagosome Formation"]
    G --> H["Cargo Recognition (p62/SQSTM1)"]
    H --> I["Autophagosome-Lysosome Fusion"]
    I --> J["Cargo Degradation"]
    J --> K["Amino Acid Recycling"]
    K --> L["Cell Survival"]
    M["Autophagy Impairment in Aging"] --> N["Aggregate Accumulation"]
    N --> O["Tau, Abeta, alpha-Synuclein Buildup"]
    O --> P["Neurodegeneration"]
    style L fill:#1b5e20,color:#e0e0e0
    style P fill:#ef5350,color:#e0e0e0
    style G fill:#006494,color:#e0e0e0

Introduction

Autophagy-impaired neurons represent a pathological state characterized by defective autophagic degradation, leading to the accumulation of dysfunctional organelles, protein aggregates, and other cellular debris that would normally be cleared through the autophagy-lysosome pathway [1]. Autophagy (meaning “self-eating”) is a critical cellular housekeeping mechanism that maintains neuronal health by removing damaged components, recycling nutrients, and eliminating potentially toxic protein aggregates [2]. When autophagy fails, neurons become vulnerable to proteotoxic stress, mitochondrial dysfunction, and eventual cell death [3]. ^{2Hardie, D.G. (2007). AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nature Reviews Molecular Cell Biology2007 · DOI 10.1038/nrm2193Open reference}8

Unlike most other cell types, neurons are particularly dependent on autophagy due to their post-mitotic nature. Without the ability to divide and dilute accumulated damage, neurons rely heavily on autophagy to maintain cellular homeostasis throughout the lifespan [4]. This makes autophagy impairment particularly devastating for neuronal function and survival. ^{2Hardie, D.G. (2007). AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nature Reviews Molecular Cell Biology2007 · DOI 10.1038/nrm2193Open reference}9

Molecular Mechanisms

Autophagy Initiation Defects

mTORC1 hyperactivation: Inhibits ULK1 complex formation [5]
AMPK dysfunction: Fails to activate autophagy during stress [6]
ULK1/2 mutations: Impaired initiation complex [7]
Beclin-1 deficiency: Reduced autophagosome nucleation [8]

Autophagosome Formation

ATG proteins deficiency: Failed conjugation systems [9]
LC3 lipidation defects: Impaired membrane recruitment [10]
ATG5/ATG7 mutations: Blocked autophagosome formation [11]
ATG16L1 dysfunction: Failed ATG5-ATG12 complex [12]

Lysosomal Dysfunction

Cathepsin deficiency: Impaired protein degradation [13]
LAMP2 mutations: Danon disease with neurodegeneration [14]
V-ATPase impairment: Failed acidification [15]
Lysosomal storage diseases: Accumulation of undegraded material [16]

Cargo Recognition and Delivery

p62/SQSTM1 dysfunction: Failed selective autophagy [17]
NBR1 deficiency: Impaired aggregate clearance [18]
OPTN mutations: Defective mitophagy [19]
Tollip dysfunction: Impaired innate immunity autophagy [20]

Types of Autophagy Defects

Macroautophagy

Autophagosome formation defects: Impaired initiation and elongation [21]
Cargo recognition failures: Selective autophagy impairments [22]
Fusion障碍: Autophagosome-lysosome fusion problems [23]
Lysosomal degradation defects: Final step failure [24]

Mitophagy

PINK1/Parkin pathway dysfunction: Failed mitochondrial quality control [25]
OPTN deficiency: Impaired receptor-mediated mitophagy [26]
FUNDC1 mutations: Hypoxia-induced mitophagy defects [27]
BNIP3/NIX dysfunction: Alternative mitophagy pathway [28]

Chaperone-Mediated Autophagy

LAMP-2A deficiency: Impaired CMA receptor function [29]
HSC70 dysfunction: Failed substrate recognition [30]
CMA substrate accumulation: Specific protein accumulation [31]

Ribophagy and ER-Phagy

Ribophagy defects: Impaired ribosomal turnover [32]
ER-phagy receptor dysfunction: Failed ER clearance [33]

Cellular Consequences

Protein Aggregate Accumulation

Ubiquitin-positive inclusions: Accumulated misfolded proteins
Autophagic vacuole accumulation: Failed degradation [35]
Aggresome formation: Microtubule-dependent inclusions [36]
Impaired proteostasis: Global protein quality control failure [37]

Mitochondrial Dysfunction

Damaged mitochondria accumulation: Failed mitophagy
Energy deficit: Reduced ATP production
ROS overproduction: Oxidative stress accumulation
Calcium buffering impairment: Dysregulated calcium

Lysosomal Pathology

Lipofuscin accumulation: Age-related pigment [42]
Ceroid accumulation: Lysosomal storage [43]
Lysosomal membrane permeabilization: Cell death activation [44]
**Autoimmune lysosomal dysfunction: Disease-specific patterns [45]

Role in Alzheimer’s Disease

Autophagy-Vacuole Accumulation

Autophagic vacuoles in AD: Characteristic pathology [46]
Beclin-1 reduction: Impaired autophagosome formation [47]
mTOR hyperactivation: Inhibited autophagy initiation [48]
Lysosomal dysfunction: Cathepsin deficiency [49]

Amyloid and Tau Effects

Aβ-induced autophagy defects: Toxic oligomer effects [50]
Tau-mediated autophagy impairment: Phosphorylated tau [51]
Presenilin mutations: Impaired lysosomal acidification [52]

Therapeutic Implications

mTOR inhibitors: Rapamycin enhances autophagy [53]
Lithium: Autophagy induction [54]
Carbamazepine: TFEB activation [55]

Role in Parkinson’s Disease

Mitophagy Defects

PINK1 mutations: Impaired mitophagy initiation [56]
Parkin mutations: Failed substrate recognition [57]
DJ-1 deficiency: Impaired mitophagy regulation [58]
Complex I deficiency: Mitochondrial damage accumulation [59]

Alpha-Synuclein Clearance

Impaired autophagic degradation: Aggregate accumulation [60]
p62 dysfunction: Failed selective autophagy [61]
GCH1 deficiency: Impaired dopamine synthesis [62]

Neuroprotection Strategies

Urolithin A: Mitophagy induction [63]
CoQ10: Mitochondrial support [64]
NAD+ precursors: Sirtuin activation [65]

Role in Huntington’s Disease

Mutant Huntingtin Effects

Huntingtin sequestration of beclin-1: Impaired autophagy [66]
Transcriptional dysregulation: Autophagy gene suppression [67]
Aggregate-mediated inhibition: Autophagic flux blockade [68]

Autophagy Enhancement

mTOR inhibition: Rapamycin treatment [69]
Minocycline: Autophagy enhancement [70]
Lithium: Autophagy induction [71]

Role in Amyotrophic Lateral Sclerosis

Autophagy Defects

ALS-associated mutations: Multiple autophagy genes [72]
SOD1 aggregates: Impaired clearance [73]
TDP-43 pathology: Autophagic stress [74]

Therapeutic Approaches

Arimoclomol: HSP induction [75]
Rapamycin: Autophagy enhancement [76]
Trehalose: Autophagy inducer [77]

Therapeutic Strategies

Pharmacological Induction

Rapamycin/sirolimus: mTORC1 inhibition [78]
Lithium: GSK3β inhibition and autophagy [79]
Carbamazepine: ER stress and autophagy [80]
Metformin: AMPK activation [81]

Natural Compounds

Resveratrol: SIRT1 activation [82]
Curcumin: Autophagy modulation [83]
Sulforaphane: Nrf2-mediated autophagy [84]
Trehalose: mTOR-independent autophagy [85]

Gene Therapy

ATG gene delivery: Restore missing components [86]
Beclin-1 overexpression: Enhance initiation [87]
TFEB activation: Lysosomal biogenesis [88]

Research Models

In Vitro Models

3-MA treatment: Pharmacological inhibition [89]
BafA1 treatment: Lysosomal blockade [90]
ATG knockout neurons: Genetic models [91]
Patient iPSC neurons: Disease-specific defects [92]

In Vivo Models

ATG5/ATG7 knockout mice: Neuron-specific deletion [93]
mTORC1 knockout: Hyperactive autophagy [94]
PINK1/Parkin knockouts: Mitophagy defects [95]
[Aging models: Natural autophagy decline [96]
Protein Aggregate-Bearing Neurons
Oxidatively Damaged Neurons
Mitochondrially Impaired Neurons
Alzheimer’s Disease
Parkinson’s Disease
Huntington’s Disease
Cell Types Index

References

Laplante, M. & Sabatini, D.M. (2009). mTOR signaling at a glance. Journal of Cell Science 2009 · DOI 10.1242/jcs.051011
Hardie, D.G. (2007). AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nature Reviews Molecular Cell Biology 2007 · DOI 10.1038/nrm2193
(2009). ULK1.ATG1.FIP200 complex. Autophagy Jung, C.H. et al. 2009 · DOI 10.4161/auto.5.6.8902
He, C. & Levine, B. (2010). The Beclin 1 interactome. Current Opinion in Cell Biology 2010 · DOI 10.1016/j.ceb.2010.02.008
(2011). Autophagy machinery in mammalian cells. Cell Death & Differentiation Mizushima, N. et al. 2011 · DOI 10.1038/cdd.2010.82
(2000). LC3, a mammalian homologue of yeast Apg8p. EMBO Journal Kabeya, Y. et al. 2000 · DOI 10.1093/emboj/cdg440
(2004). The role of autophagy during the newborn period. Nature Kuma, A. et al. 2004 · DOI 10.1038/nature03029
(2003). Mouse Apg16L, a novel WD-repeat protein. Journal of Biological Chemistry Mizushima, N. et al. 2003 · DOI 10.1074/jbc.M212599200
(2006). Lysosomal cathepsins and cell death. Antioxidants & Redox Signaling Stoka, V. et al. 2006 · DOI 10.1089/ars.2006.8.188
(2000). Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy. Nature Nishino, I. et al. 2000 · DOI 10.1038/35065114
Marshansky, V. & Futai, M. (2008). The V-type H+-ATPase in vesicular trafficking. Current Opinion in Cell Biology 2008 · DOI 10.1016/j.ceb.2008.05.003
Futerman, A.H. & van Meer, G. (2004). Lipid metabolism. Nature Reviews Molecular Cell Biology 2004 · DOI 10.1038/nrm1415
(2009). A role for p62/SQSTM1 in the activation of NF-kB. Molecular Cell Kirkin, V. et al. 2009 · DOI 10.1016/j.molcel.2009.01.037
(2009). NBR1 cooperates with p62 in selective autophagy. Journal of Cell Biology Kirkin, V. et al. 2009 · DOI 10.1083/jcb.200908115
(2011). Phosphorylation of the autophagy receptor OPTN. Science Wild, P. et al. 2011 · DOI 10.1126/science.1196348
Myrvik, Q.N. & Jean, P.A. (1983). Tollip in innate immunity. Journal of Immunology 1983 · PMID 6339632
Reggiori, F. & Klionsky, D.J. (2002). Autophagy in the eukaryotic cell. Eukaryotic Cell 2002 · DOI 10.1128/EC.1.1.11-21.2002
Johansen, T. & Lamark, T. (2011). Selective autophagy. Autophagy 2011 · DOI 10.4161/auto.7.3.14027
Fader, C.M. & Colombo, M.I. (2009). Autophagy and multivesicular bodies. Autophagy 2009 · DOI 10.4161/auto.5.7.9290
(2012). Signals from the lysosome. Nature Reviews Molecular Cell Biology Settembre, C. et al. 2012 · DOI 10.1038/nrm3230

Sister wikis (recently updated · no domain on this page)

Recent activity here

No recent events touching this page.